Patents by Inventor Boris Czermak

Boris Czermak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for the threatment of sepsis
    Publication number: 20060159684
    Abstract: The present invention relates to compositions and methods for the prevention and treatment of blood-borne and toxin mediated diseases, and in particular anti-C5a antibodies for the prevention and treatment of sepsis in humans as well as other animals. The present invention also relates to methods of generating anti-C5a antibodies employing C-terminal truncated C5a peptides.
    Type: Application
    Filed: September 27, 2005
    Publication date: July 20, 2006
    Applicant: The Regents of The University Of Michigan
    Inventors: Peter Ward, Markus Huber-Lang, Vidya Sarma, Boris Czermak
  • Compositions and methods for the treatment of sepsis
    Patent number: 6987166
    Abstract: The present invention relates to compositions and methods for the prevention and treatment of blood-borne and toxin mediated diseases, and in particular anti-C5a antibodies for the prevention and treatment of sepsis in humans as well as other animals. The present invention also relates to methods of generating anti-C5a antibodies employing C-terminal truncated C5a peptides.
    Type: Grant
    Filed: June 11, 2001
    Date of Patent: January 17, 2006
    Assignee: The Regents of the Univeristy of Michigan
    Inventors: Peter A. Ward, Markus Huber-Lang, Vidya Sarma, Boris Czermak
  • Compositions and methods for the treatment of sepsis
    Patent number: 6673346
    Abstract: The present invention relates to compositions and methods for the prevention and treatment of blood-borne and toxin mediated diseases, and in particular anti-C5a antibodies for the prevention and treatment of sepsis in humans as well as other animals. The present invention also relates to methods of generating anti-C5a antibodies employing C-terminal truncated C5a peptides.
    Type: Grant
    Filed: August 31, 1999
    Date of Patent: January 6, 2004
    Assignee: The Regents of the University of Michigan
    Inventors: Peter A. Ward, Markus Huber-Lang, Vidya Sarma, Boris Czermak
  • Compositions and methods for the treatment of sepsis
    Publication number: 20020165138
    Abstract: The present invention relates to compositions and methods for the prevention and treatment of blood-borne and toxin mediated diseases, and in particular anti-C5a antibodies for the prevention and treatment of sepsis in humans as well as other animals. The present invention also relates to methods of generating anti-C5a antibodies employing C-terminal truncated C5a peptides.
    Type: Application
    Filed: June 11, 2001
    Publication date: November 7, 2002
    Applicant: The Regents of The University of Michigan
    Inventors: Peter A. Ward, Markus Huber-Lang, Vidya Sarma, Boris Czermak